锚定表达GM-CSF疫苗的抑瘤效果研究  

The Antitumor Effects of Tumor Vaccine with Expression of Granulocyte-Macrophage Colony-Stimulating Factor Anchored on Mouse Melanoma Tumor Cell Surface

作　　者：程绍辉[1] 马晓慧[1] 陈兴[2] 于继云[2] 

机构地区：[1]北京工业大学生命科学与生物工程学院,北京100022 [2]北京军事医学科学院基础所,北京100850

出　　处：《中国肿瘤生物治疗杂志》2004年第1期27-30,共4页Chinese Journal of Cancer Biotherapy

基　　金：863计划项目(2001AA217131)资助

摘　　要：目的:研究锚定表达GM—CSF的小鼠黑色素瘤作为肿瘤疫苗的有效性。方法:GM-CSF基因嵌合GPI信号肽修饰序列实现在B16小鼠黑色素瘤细胞表面的锚定表达,研究锚定修饰的B16细胞于同源C57BL/6小鼠的成瘤性及诱导抗肿瘤免疫的效果。结果:抑瘤实验结果表明,锚定修饰GM—CSF的肿瘤细胞免疫原性增强,成瘤性明显下降;成瘤率为58.8％,而肿瘤对照组为100％。活瘤苗接种实验结果显示锚定修饰的肿瘤细胞可以预防肿瘤的发生,肿瘤发生率仅为20％,说明抗肿瘤的免疫应答有记忆性,能够有效地防止野生型肿瘤细胞的攻击。结论:锚定修饰GM-CSF的肿瘤细胞可以诱导抗特异性的抗肿瘤反应,这种设计可以应用于肿瘤疫苗的研究中。Objective: To investigate the vaccine potency of GM-CSF anchored B16 tumor cells. Methods: In this study, mGM-CSF was expressed on surface of B16 mice melanoma cells by GPI-modifying. C57BL/6 mice were inoculated with GM-CSF anchored cells and wide-type B16 cells to evaluate whether the GM-CSF anchored cells could elicit a protective and systemtic antitumor response. Results: GM-CSF anchored cells resulted in remarkable loss of tumorgenicity in syngenetic mice. The tumor occurrence rate of GM-CSF anchored B16 cells was 58. 8% on C57BL/6 mice with 1 × 106 B16 cells/mice inoculated ( n = 12) and that of wide-type B16 cells was 100% , The C57BL/6 mice receiving inoculation with 5 × 105GM-CSF anchored cells/mice never grew tumor. These mice were challenged with wide-type B16 cells, and only a minority of mice grew tumor after wide-type B16 cells inoculation. Conclusion:GM-CSF protein anchored cells could elicit a protective and systemtic antitumor responses.

关 键 词：膜表达 GM—CSF 抗肿瘤免疫 

分 类 号：R730.5[医药卫生—肿瘤]